|
MBD5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.69030386646341E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.94209101525666E-14 |
| Normal-vs-Stage2 |
6.33120000870235E-09 |
| Normal-vs-Stage3 |
1.67410529883227E-11 |
| Normal-vs-Stage4 |
5.57589974192751E-10 |
| Stage1-vs-Stage2 |
4.676800E-01 |
| Stage1-vs-Stage3 |
1.352400E-01 |
| Stage1-vs-Stage4 |
4.857400E-01 |
| Stage2-vs-Stage3 |
7.310600E-01 |
| Stage2-vs-Stage4 |
9.566000E-01 |
| Stage3-vs-Stage4 |
6.621200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.96930282981134E-11 |
| Normal-vs-AfricanAmerican |
4.456700E-03 |
| Normal-vs-Asian |
1.07219999545549E-08 |
| Caucasian-vs-AfricanAmerican |
1.459900E-02 |
| Caucasian-vs-Asian |
7.838200E-01 |
| AfricanAmerican-vs-Asian |
5.633600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.61860533257163E-11 |
| Normal-vs-Female |
1.6251444634463E-12 |
| Male-vs-Female |
3.127600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.30890870259282E-12 |
| Normal-vs-Age(41-60Yrs) |
3.62265772935189E-13 |
| Normal-vs-Age(61-80Yrs) |
7.64366347993928E-12 |
| Normal-vs-Age(81-100Yrs) |
1.589100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.216800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.373700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.066000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.402020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.937800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.128400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.006300E-02 |
| Classical-VS-Follicular |
2.304400E-01 |
| Classical-VS-Other |
7.544200E-01 |
| Classical-VS-Normal |
3.93720001046205E-09 |
| Tall-VS-Follicular |
3.782800E-01 |
| Tall-VS-Other |
6.176200E-01 |
| Tall-VS-Normal |
1.10879971870759E-10 |
| Follicular-VS-Other |
8.928200E-01 |
| Follicular-VS-Normal |
7.13930026208232E-10 |
| Other-VS-Normal |
7.602400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-15 |
| Normal-vs-N1 |
5.14380005256498E-09 |
| N0-vs-N1 |
9.427600E-01 |
|
|
